Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMW 2019 | Myeloma: tackling high-risk disease

Amrita Krishnan • 13 Sep 2019
IMW 2019
Multiple Myeloma

Amrita Krishnan, MD, City of Hope, Duarte, CA, discusses what future research would be most pertinent for the treatment of newly diagnosed and high-risk myeloma at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

More from Amrita Krishnan

0:49
Management of patients with penta-class refractory myeloma
Amrita Krishnan • 11 Dec 2023
1:01
Considerations to optimize the outcomes of bispecific antibody treatment in patients with myeloma
Amrita Krishnan • 11 Dec 2023
0:50
Dose modifications of talquetamab to manage AEs in patients with multiple myeloma
Amrita Krishnan • 11 Dec 2023
1:15
How BCMA targeting bispecific antibodies may impact the subsequent use of CAR-T therapy in myeloma
Amrita Krishnan • 29 Sep 2022

Related Videos

0:59
Looking forward to COMy 2024: celebrating 10 years
Mohamad Mohty • 17 Apr 2024
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024
1:45
Expanded approval of cilta-cel in myeloma: the value of bringing CAR-T cells into earlier lines
Monika Engelhardt • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals